Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Viral Hepatitis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00128544
What this trial is testing

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis B
Novartis 130
Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Early research (Phase 1)Study completedNCT02014571
What this trial is testing

Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 37
Testing effectiveness (Phase 2)UnknownNCT00225537
What this trial is testing

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
MTmedical Institute of Health 160
Post-approval studies (Phase 4)UnknownNCT02463019
What this trial is testing

Roll-over After 3-year Trial for Tenofovir in Mild Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis BAntiviral Treatment
E-DA Hospital 160
Large-scale testing (Phase 3)Study completedNCT00412529
What this trial is testing

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hepatitis B
Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)WithdrawnNCT05953545
What this trial is testing

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Who this might be right for
Chronic Hepatitis Delta
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Not applicableEnded earlyNCT00705107
What this trial is testing

Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 267
Not applicableStudy completedNCT02791386
What this trial is testing

Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy

Who this might be right for
Hepatitis B
Bristol-Myers Squibb 383
Very early researchNot Yet RecruitingNCT06745973
What this trial is testing

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Epigenic Therapeutics, Inc 20
Not applicableStudy completedNCT00725751
What this trial is testing

Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 353
Not applicableStudy completedNCT01013272
What this trial is testing

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Who this might be right for
Hepatitis B, Chronic
The University of Hong Kong 50
Post-approval studies (Phase 4)Study completedNCT01732367
What this trial is testing

TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA

Who this might be right for
Chronic Hepatitis B
Keimyung University Dongsan Medical Center 171
Testing effectiveness (Phase 2)Ended earlyNCT05760781
What this trial is testing

To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
Staidson (Beijing) Biopharmaceuticals Co., Ltd 9
Not applicableUnknownNCT02510963
What this trial is testing

Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy

Who this might be right for
Hepatitis B, Chronic
First Affiliated Hospital Xi'an Jiaotong University 300
Not applicableUnknownNCT05812612
What this trial is testing

UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease

Who this might be right for
COVID-19 Infection
Beijing Ditan Hospital 2,000
Not applicableUnknownNCT01464281
What this trial is testing

Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml

Who this might be right for
Chronic Hepatitis B
The Second Affiliated Hospital of Chongqing Medical University 300
Testing effectiveness (Phase 2)UnknownNCT04111367
What this trial is testing

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients

Who this might be right for
Hepatitis C Virus Infection
Ginkgopharma CO., LTD 36
Testing effectiveness (Phase 2)Ended earlyNCT02065336
What this trial is testing

Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B, Chronic
Arrowhead Pharmaceuticals 58
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation